Tue May 20 16:00:00 UTC 2025: Okay, here’s a summary and news article rewrite based on the provided text:

**Summary:**

The FDA is expected to approve updated COVID-19 vaccines this fall for adults over 65 and those with specific medical conditions. However, approval for healthy individuals under 65 may be delayed pending additional clinical trial data. FDA officials suggest the benefit of the new shots is “uncertain” for younger, previously vaccinated, or COVID-recovered individuals. They also acknowledged low public enthusiasm for recent COVID-19 vaccines.

**News Article:**

**FDA to Prioritize Updated COVID Vaccines for Seniors and High-Risk Individuals**

WASHINGTON – The Food and Drug Administration (FDA) is poised to approve updated COVID-19 vaccines for adults aged 65 and older, as well as individuals with certain medical conditions, this fall, according to agency officials. However, younger, healthy adults may face a delay in accessing the new shots as the FDA considers requiring additional clinical trial data.

In an article published in The New England Journal of Medicine, FDA officials, including vaccine division chief Dr. Vinay Prasad and Commissioner Dr. Martin Makary, stated that the benefits of the new vaccines for many Americans under 65 who have already been vaccinated or have had COVID-19 are “uncertain.”

The officials also acknowledged low public demand for recent COVID-19 vaccines, citing a lack of widespread conviction that the shots are necessary.

“The F.D.A. will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk,” Dr. Prasad and Dr. Makary wrote, signaling a cautious approach to broad authorization.

Read More